Biomerica (BMRA) has announced that its Fortel prostate-specific antigen screening test has gained approval from the UAE Ministry of Health and Prevention. The Fortel PSA test is an easy-to-use diagnostic tool that provides accurate results in just 10 minutes using an undeniable fingertip. blood sample. By measuring elevated levels of PSA, an identified early marker of prostate disease, the test may allow for early detection of prostate cancer and other prostate-related conditions. This timely and available technique aims to proactively monitor physical status. reduce the burden on fitness systems and patient outcomes.
First published on TheFly, the source for real-time monetary news and market news. Try it now>>
Check out today’s most sensible stocks on TipRanks >>
Learn more about BMRA: